Biogen beats Q3 2026 estimates with revenue of $2.80 billion
FROM THE WIRE · THESTOCKMARKETWATCH.COM
Biogen (BIIB) reported robust third-quarter 2026 results, with total revenue reaching $2.80 billion, exceeding the consensus estimate of $2.64 billion. The
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRevenue above consensus can support the shares of a major biotech.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Biogen reported its third-quarter 2026 results.
- 02Total revenue reached $2.80 billion.
- 03The analyst consensus estimate was $2.64 billion.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets